Cluster: Health Economy

Syngenta CEO: ‘No formal decision has been made on a potential IPO’

This content was published on Feb 28, 2026 Jeff Rowe, CEO of the Syngenta Group, headquartered in Switzerland, explains why being Chinese-owned is good for the company.

The Swiss are set to vote on the issue of GMO food

Agribusiness

Swiss anti-GMO initiative handed in at Bern

This content was published on Feb 27, 2026 Swiss anti-GMO initiative handed in with 137,000 signatures.

New treatments

Switzerland’s bitter-sweet news for Alzheimer’s patients

This content was published on Feb 27, 2026 Swissmedic was expected to approve two drugs for Alzheimer‘s disease. But it only approved one. What happened?

Food safety

Does infant formula have too many ingredients?

This content was published on Feb 26, 2026 Several European countries, including in Switzerland, have reported illnesses that may be linked to toxic contamination in infant formula.

There have been reports of hospitalisation of infants who were fed the recalled formula in France and Spain.

Food safety

Infant formula recall: Is trying to copy breastmilk increasing risk of contamination?

This content was published on Feb 25, 2026 A contaminated additive found naturally in breastmilk is responsible for the recent recall of infant formula worldwide.

The banking sector has been particularly affected by redundancies.

Pharma supply chains

Why unemployment in Switzerland is increasing more than elsewhere in Europe

This content was published on Feb 24, 2026 The number of people in Switzerland who are out of work increased for the second year in a row. This contrasts with the situation in the European Union.

Roche obtains FDA approval to treat a form of leukaemia

New treatments

FDA approves Roche leukaemia treatment

This content was published on Feb 20, 2026 Genentech obtains FDA approval for treatment for chronic lymphocytic leukaemia (CLL).

Production of cigarettes at a factory in Switzerland

Prevention

Links between universities and tobacco industry a threat to Swiss research, NGO warns

This content was published on Feb 19, 2026 An investigation by the Transparency and Truth initiative of the NGO OxySuisse reveals links between the tobacco industry and several Swiss universities.

Top-selling drugs discounted to lower premiums

Drug pricing

Switzerland mulls discounts on top-selling drugs to cut health costs

This content was published on Feb 19, 2026 The Swiss government has opened a consultation on limiting the steady rise of healthcare costs by granting discounts on best-selling medicines in the country.

Ketamine consumption is on the rise in Switzerland

Health systems

Swiss wastewater analysis shows increase in ketamine, crack cocaine use

This content was published on Feb 19, 2026 More use of ketamine and crack cocaine, but slightly less of cannabis and crystal meth: these are the results of analyses of Swiss wastewater published on Thursday.

Cluster: Health Economy

Popular Stories

Most Discussed